Deprecated: wp_make_content_images_responsive is deprecated since version 5.5.0! Use wp_filter_content_tags() instead. in /var/www/idih/wp-includes/functions.php on line 4773
Catalyst @ Health 2.0 (“Catalyst”) was founded by Indu Subaiya and Matthew Holt in 2010 through organic demand from healthcare leaders interested in unique health technologies. Through the Health 2.0 conference business, Indu and Matthew formed a team to focus on small consulting projects, code-a-thons, and innovation competitions. As the demand for digital health innovation grew dramatically, Catalyst’s services evolved to fulfill the consulting needs of some of the largest healthcare institutions around the globe. In 2017, Catalyst was spun-off from Health 2.0’s conference arm to focus on novel and diverse digital health innovation programs.
Catalyst is the industry leader in digital health strategic partnering, hosting competitive innovation “challenge” events, as well as developing and implementing programs for piloting and commercializing novel healthcare technologies. Since 2010, Catalyst has hosted 90+ innovation challenges with $9mm in awards, coordinated over 175 pilot programs to test new technologies, and created connections for more than 1,500 firms via matchmaking events. Catalyst has also organized and hosted 25+ code-a-thons with software engineers and programmers involved in the health technology community. Through this work, Catalyst has tracked and showcased the connected mobile, web, and cloud revolution in health information technology. Their unique industry positioning and unrivaled depth of knowledge have been used to form a proprietary database, Source DB, that contains detailed information on more than 4,500 companies, 6,500 products, and 14,000 individuals.
Catalyst’s consulting services have served many clients with digital health innovation and commercialization across the public and private sectors. Their global network is a community comprised of health information technology and new-media entrepreneurs, software developers, health care provider and payer organizations, pharmaceutical companies, philanthropic foundations, physicians, patients, academics and government representatives.